Don't worry bout the mule, just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You post BS. Made up stuff like you know what you are talking about. What a joke.
Pretty simple so you know the facts. I think the CEO is going to re-emerge. Maybe not but
I will try to be in a great position should this in fact make a come back. No hurry. Patience has been a moneymaker here thus far after pivoting away from the tatoo baby. When you want a trading lesson, let me know.
Something I learned long ago. Assume very little but do assume there are abusive shorts.
Should it dip below 10 thinking to re-enter.
LMAO, sure you do.
TÜBINGEN, Germany/BOSTON, USA – July 11, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced the latest trial dates for its ongoing patent litigation against Pfizer/BioNTech in multiple geographies including the U.S., UK and Germany.
The U.S. trial against Pfizer/BioNTech will take place on March 3, 2025, before the U.S. District Court of the Eastern District of Virginia. A previously issued court recommendation to stay the proceedings for all 10 U.S. patents was withdrawn. The recommendation had followed a motion by Acuitas Therapeutics to intervene, sever and stay proceedings based on co-owner and co-inventorship claims. It was resolved after both companies reached a settlement in April 2024, which provided Acuitas licenses to several patents, including three out of four disputed U.S. patents. These three patents have been withdrawn from the U.S. patent litigation against Pfizer/BioNTech. In return, Acuitas acknowledges that CureVac is the sole owner of the disputed patents.
Litigation in Europe will continue March 25, 2025, with a hearing on the validity of EP 3 708 668 B1 (split poly-A tail technology), before the Opposition Division of the European Patent Office. The infringement action in relation to this patent was previously suspended pending the validity determination by the European Patent Office. In the German patent litigation against Pfizer/BioNTech, the settlement with Acuitas Therapeutics led to the withdrawal of two utility models covering equivalent claims to the three patents withdrawn in the United States. As previously announced, a hearing before the infringement court of Düsseldorf covering the European patent EP 4 023 755 B1 (split poly-A tail technology) and the utility model DE 20 2021 004 130 U1 (COVID-19 vaccine design), is scheduled for September 10, 2024.
Furthermore, a trial in the UK has started on July 10, 2024. It is based on a declaration of non-infringement and request for revocation by Pfizer/BioNTech in the UK for the two CureVac patents EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A-tail technology). CureVac counterclaimed for infringement. A judgement is expected later in 2024. The trial for the further involved patent EP 1 857 122 B1 (G/C enrichment technology) will be set for a later time point.
No not at all. No one believes you for making up lies about other traders and pretending you know when they bought and sold. Such contortions of reality on a consistent basis by one who does not claim to own the stock is sheer falsity (fantasy). Or are you just trying to snare me and others in falsehood so as to appear superior?
It used to be funny stuff. Enough already, it now borders on the weird.
I hope the oral version has better efficacy than the Covid Paxlovid.
Wonder if he was one of the lucky ones working at Pfizer who did not choose the jab? Could be he took that special jab not offered to the public similar to the ones offered to Pfizer employees over in Australia. Who knows what is he feeling or thinking. Could be he is suffering and wants to play hard with his blood money before his next infarction. Hard to say. For his sake I hope his conscious is clean and his health is good. Amen.
Oh that was a lovely channel. Perhaps let's call it Channel #5. The one that was so sweet to me riding up down the channel, but DJ would not budge and missed out soooo many times. Sad. Well, hang around and learn. There may be some more sweet smelling Channel on the horizon. Will let you know. But first, one must learn how to read and play and speak without doing the limbo too low. Say, do you think shortie covered yet? LMAO
And 90% green. Even my few shorts made money....especially the jab stocks.
Green is good.
Now with this one... it all depends on the final outcome of the legal junk and how it proceeds from there.
Tempted to buy in again. I hold a few still just to keep an eye on it. So far so good even still!!
I am rooting for Mick. Let's see how it goes. I would love to pile back in. Waiting....
Good bear hunting!!
Yes, and he speaks clearly and can find his way off the drilling platform without getting lost or falling down. He has my vote.
Seems some are scared listless with continuous lying posts on purpose.
This is a good moment to add.
Look at my recommendations to DJ... on track and always a money maker. It's all in the timing not in phony analysis. It's called channel trading. Anyone can make a buck. Try it, it is a winnable solution.
https://stockanalysis.com/stocks/cydy/
"The terms of the settlement provide an immediate influx of non-dilutive cash and eliminates $14 million of accounts payable. Importantly, the settlement ends the potential distraction and uncertainty associated with protracted litigation and allows the Company to immediately advance its clinical trials and research and development initiatives, said Dr. Jacob Lalezari, CEO.”
TIck TIck Tick..... Sidley pre-paid, thanks!, 6.5 $$$ million bond released, thanks!,14$$milly eliminated, thanks!, 12$$ milly influx, thanks Kareem, 32.5 $$ milly credited to our account!! Plus the earlier Samsung agreement... I WOULD SAY WE ARE GOOD TO GO TRIAL WISE!! new partner ???
$$CYDY$$ 2024
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC Laboratories, Inc. (“SMC”) has commenced, with results expected in the fall of 2024.
CytoDyn believes its prior MASH study demonstrated a statistically significant benefit of leronlimab at a dosing level of 350 mg. To clarify the optimal dosing and evaluate the potential for combination therapy, SMC will be conducting a twelve-week preclinical mouse study evaluating both 350 and 700 mg dose levels, alone and in combination with Resmetirom, a drug recently approved by the FDA. The study will evaluate leronlimab’s potential role in preventing and/or reversing liver fibrosis.
CytoDyn’s CEO, Dr. Jacob Lalezari, stated, “in addition to clarifying dosing and efficacy, the goal of this study is to eventually use the results to pursue partnerships in the MASH space. Although CytoDyn will be primarily focused on oncology and inflammation in the coming months, we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”
We are grateful having boots on the ground. Keep on keeping on!
right on. bot and buying more.
Ugandan military conscripted him and he is now in Haiti trying to restore order.
Made good bank on NVAX to make up for my losses here. Still hold a few at 3.91, sold at 15.26. Will jump back in under $10 as the shorts are piling on still.
As to the jab, no thanks, not any of any kind especially mRNA variety. Knowing what you put in your body is more important than being right or wrong in the highly manipulated stock market. After intense scrutiny and many years of researching TCM, I would certainly take the products offered by Todos and never take the jabs.
Due diligence pays especially for anyone who desired to live longer and healthier.
Jay is a mover and shaker. I like his fighting spirit and savvy as to how the health system functions and malfunctions. This is the leadership we have needed to advance leronlimab. With his team we have seen great strides in the past year. The PPS is going to go nuts when new trials begin.
We all know it's coming especially the shorts. There will be some big money entering the scene which will set off a short squeeze. Some large buys are being noted. Whether the pps goes up or down a few points with the same typical volume is meaningless. Yesterday especially but for the past week or so, the pps has steadily inched up having observed a changing behavior. Astute and aware traders and investors are again entering. On this forum we will see some new faces appear and some others from the past return. We all have known it is just a matter of time, those who truly know and appreciate our candidate leronlimab.
The recognition of the sthenic immense talent of Dr. Jay Lalezari by Board Chair Tanya Urbach has been key to this turn around. Leadership is everything. With leronlimab as our product great advances are in store. We are truly blessed to be part of this history.
This is a good time to re-familiarize with all the talent we possess. Read the website and know those involved in your company. Know what you own. $CYDY$ 2024
Who would consent knowing this?
https://petermcculloughmd.substack.com/p/a-pandoras-box-in-the-pharma-lab?publication_id=1119676&post_id=146401978&triggerShare=true&isFreemail=true&r=x7hm&triedRedirect=true
Well, PFE just shoots from the hip. No toxicology studies? OMG
Oh heck, they mean well. Guess I'll just bend over.
Knowing some of the facts that have been exposed....who in their right mind would invest in this company except to squeeze some profit from the pps movement?
Hope they don't explode!
California needs a gold rush. So much money is relocating out of state. Especially now seeing the green dream is no longer supreme.
Here's to some rip snorter rain and snow storms. Nothing like God's erosion machine to reveal some hidden nuggets.
So we can expect a ProActive Video interview update once the mill is fired up and the first gold runs have begun. That should be coming fairly soon.
Well the fda has plenty of experience over the decades of issuing permits to experiment on the public. Ahemm.... so it may take Charlie or Delta 4.0 version of Evie to become successful. Anyway, how amazing sometimes the solving of a little problem like the possible bending creating the crystalization of the battery and how the solution may have far ranging applications.
In the meantime, are the 20 some odds sales force making any deals? Can a sales rep via Ihub leak some info? Seems leaks are in vogue.
Just do it. Throw us a bone.
Good info thanks.
As has been brought up a few times in the past. DoD applications can be kept silent and income side pocketed. Yes, who is benefiting now and who will in the future? I sure hope no damn bio weapons are involved. Will be obliged to turn around and go short if ever so.
Where is the bottom? A great company run by an almost too savvy CEO. I don't really dislike him for what he is creating. Just that all is not how made to appear. Yes, I do believe in the tech. That seems to have been proven. Here is his game; Spin Outs! How so? In order to raise capital and pad his account as well, just spin off these different applications. This creates demand for the shares and with that volume the dilution/shorting begins again. Now is he doing the shorting. Probably not, but some of the other founders and loan sharks may be doing both...most likely along with their buds who pass it on down the line as far as it can go. Then the trash talk begins along with the pumping. A choir could not sing a better harmony. All in my lowly opinion.
Had some bird dogs trained in Lytle a few decades ago.
With the elections coming up and all the uncertainty .... gold and crypto will ignite even more.
The mill will be cranked up soon if not already. So when gold starts being refined I want to
be in as cheap as I can. So I will be trying to add more 2's and 3's. The fuse has been lit
and the five hole burn has been loaded. Count down has started. Fire in the hole.
Yes and I also believe there are other 3D sites even better.
LMAO, remember when shorts said CytoDyn would lose and pay AmarX!!
Remember when CYDY was going bankrupt? LMAO bigtime
Remember when CYDY was going to .10 centavos? LMAO
Remember when the company wasn't doing anything and no progress? LMAO
Remember when 13Dunce group was going to take over? LMAO
Remember when leronlimab was considered saline? LMAO
"The terms of the settlement provide an immediate influx of non-dilutive cash and eliminates $14 million of accounts payable. Importantly, the settlement ends the potential distraction and uncertainty associated with protracted litigation and allows the Company to immediately advance its clinical trials and research and development initiatives, said Dr. Jacob Lalezari, CEO.”
Damn, I am frustrated they didn't go for broke here. Oh well, $$ 32,500,000, that's 32 and half million dollars now a credit on the balance sheet. Durn it all.
Oh well, shall I go short in my sadness? LMAO Go for it shortie pie. Give me some more cheapies!
$$$ $CYDY$ $$$ 2024 The year of the overhaul. Get ready to rumble y'all. Sidley, come on over for a High Ball...... and some caviar. Next up? Clininical trials?
Guess I will add a few more ones. Why not, June was good to me. Feeling a bit patriotic so maybe FCGD will reward me.
I think we stand a good chance of making bank here. You never know from these levels. Many times a new direction comes
along that takes most by surprise. It's all a gamble. Looks worthy of some more coins.
Like others have said as well, many of us thought this stood a good chance but damn, didn't know a basement baby was running the show.
But hey, California hosts many such types so I guess it should come as no surprise. The pivot play sure was a game winner though. So I suppose
I owe some debt of gratitude to the kid. Was it any surprise that Mick's experience was captivating? Still is....? We shall see. I think so. All ahead go.
Risk v. Reward down here looks tempting... luscious is more like it.
Beam me up Scotty. There is no intelligent life here.
LOL, better take a hard look in the mirror. No one buys your generosity. So who do you work for in this munificent exercise?
Which will it be?
There is always room for opinions at the bar. Free expression over a few beers is the natural way to go. No need to use pronouns. Just straight and honest.
Aplauso!
Bingo. Their greed is job one.
I must say, it was a money making pleasure to find this ticker. Timing and adjusting is what distinguishes the winners from the losers.
Seems like Veronica enjoys surfing maybe she took the advice to add a cup holder board. She was all gung ho like so many us back then. But she failed to pivot as emotions got in the way of common sense.
$MICK$ Let's see how this all unfolds. Could be it won't be Mick. As the tide shifts so does my money. Swimming upstream is quite exasperating. So for now, I will bet on MICK. Reflections are so instructive. Why some fail to learn is beyond me.
Thanks. Good group of folks here. This will be interesting to watch it unfold. I like the transparency of the CEO. That has a lot of positive effect on investors. Kind of like a breath of fresh air in the OTC. That was 2018 was so true back then. As conditions changed I did too. That is the key to intelligent investing something Veronica doesn't seem to grasp. Oh well, she posts here all day long every day for some strange reason. Wonder what that could be? Meanwhile, I put my money still on Mick for now.... for now. I believe he will deliver.
Give it up V. Your agenda is beginning to show.
$ASTA$ Burn Bradlieee Burn
Found that Bradlie luv quote yet?
Incoming. We hunker down.